Live Quote · NASDAQALNYHealthcare· Biotechnology

Alnylam Pharmaceuticals, Inc.

$143.82▼ 2.71%($-4.00)
MKT CAP $19.26BNEXT EARNINGS Feb 11, 2027
50%
Bullish
TickerSpark Score
78/100
▌ Solid
80
Valuation
100
Profitability
100
Growth
80
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALNY research report →

Analyst Price Target
$331.93+130.8% vs. today

Range $225 – $455

Analyst RatingBuy
37 Buy14 Hold1 Sell

Price Chart

-67.74% · this period
$473.29$308.56$143.82Nov 20May 26Nov 20
52-Week Range0% of range
Low
$143.40
Current
$143.82
High
$479.79

AI analysis · Last refreshed November 20, 2026 · Live quote · Not investment advice